Caitong International Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History

Caitong International Asset Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-90,466	Closed	-$3.64M	–	2991
2026 Q1	$3.64M	Buy	+90,466	New	+$1.95M	0.67%	30
2025 Q3	–	Sell	-152	Closed	-$2.63K	–	1929
2025 Q2	$2.63K	Buy	152 +104	+217%	+$1.93K	﹤0.01%	1290
2025 Q1	$1.05K	Sell	48 -1,909	-98%	-$52.7K	﹤0.01%	1564
2024 Q4	$62.4K	Buy	+1,957	New	+$58.9K	0.06%	392

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caitong International Asset Management's APLS Position: Q2 2026 in Review

Caitong International Asset Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 90,466 shares — an estimated $3.64M sold.

Caitong International Asset Management first reported a position in APLS in Q4 2024 and held it in 4 quarters. The position peaked at $3.64M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Caitong International Asset Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Caitong International Asset Management sold 90,466 Apellis Pharmaceuticals shares in Q2 2026, an estimated $3.64M.
Caitong International Asset Management first reported a position in Apellis Pharmaceuticals in Q4 2024 and held it in 4 quarters.
Caitong International Asset Management's Apellis Pharmaceuticals position peaked at $3.64M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.